Description:
Crystallization is an industrially important unit operation for isolation and purification of a wide range of chemical products, including pharmaceuticals and fine chemicals. Developing a crystallization process can be challenging, often complicated by multiple components and requirements that the solids are consistently isolated in the desired polymorphic forms, compounds, adducts, or solvates. Control of particle size distribution may be needed to avoid difficult filtrations or high impurity content. This session welcomes contributions related to theoretical as well as practical approaches to crystallization process development, including techniques and tools that can lead to more efficient development of robust crystallization processes. Case studies and examples of how commercial crystallization processes are developed, and papers which describe the design and operation of batch or continuous crystallization processes are particularly encouraged.
Sponsor:
Process Research and Innovation
Co-Sponsor(s):
Solids Flow, Handling and Processing (03C), Crystallization and Evaporation (02B), Process Development Division (12)
Chair:
James C. Marek
Principal Resarch Engineer
AbbVie, Inc.
Global Pharmaceutical Research & Development
1 North Waukegan Rd
North Chicago, IL
60064-1802
Email: james.marek@abbvie.com
Principal Resarch Engineer
AbbVie, Inc.
Global Pharmaceutical Research & Development
1 North Waukegan Rd
North Chicago, IL
60064-1802
Email: james.marek@abbvie.com
Co-Chair:
Tom Xu
Scientist
DuPont
DuPont Industrial Bioscienses
Wilmington, DE
Phone Number: 302-695-8052
Email: Tom.Xu@dupont.com
Scientist
DuPont
DuPont Industrial Bioscienses
Wilmington, DE
Phone Number: 302-695-8052
Email: Tom.Xu@dupont.com
Papers:
Abstract Submissions Closed
See more of this Group/Topical: Process Development Division
